BlackRock Advisors’s Alder Biopharmaceuticals ALDR Stock Holding History

BlackRock Advisors’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$5.43M	Sell	261,025 -24,445	-9%	-$636K	0.01%	1112
2016 Q3	$9.36M	Buy	285,470 +8,783	+3%	+$267K	0.01%	890
2016 Q2	$6.91M	Buy	276,687 +28,812	+12%	+$780K	0.01%	977
2016 Q1	$6.07M	Sell	247,875 -293,176	-54%	-$6.79M	0.01%	1014
2015 Q4	$17.9M	Sell	541,051 -21,157	-4%	-$715K	0.02%	584
2015 Q3	$18.4M	Sell	562,208 -123,536	-18%	-$5.25M	0.02%	548
2015 Q2	$36.3M	Buy	685,744 +7,573	+1%	+$275K	0.04%	374
2015 Q1	$19.6M	Buy	678,171 +279,229	+70%	+$7.66M	0.02%	568
2014 Q4	$11.6M	Sell	398,942 -57,990	-13%	-$1.04M	0.01%	727
2014 Q3	$5.79M	Buy	456,932 +7,931	+2%	+$120K	0.01%	936
2014 Q2	$9.01M	Buy	+449,001	New	+$6.32M	0.01%	815

Other funds holding ALDR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

BlackRock Advisors's ALDR Position: Q4 2016 in Review

BlackRock Advisors reduced its Alder Biopharmaceuticals (ALDR) stake by 8.6% in Q4 2016, selling an estimated $636K and leaving 261,025 shares worth $5.43M. The position accounts for 0.01% of the portfolio, ranked #1112.

BlackRock Advisors first reported a position in ALDR in Q2 2014 and has held it in 11 quarters since. The position peaked at $36.3M in Q2 2015. 145 funds tracked by Wall St. Rank hold ALDR as of Q4 2016.

BlackRock Advisors held 261,025 shares of Alder Biopharmaceuticals worth $5.43M as of Q4 2016.
BlackRock Advisors sold 24,445 Alder Biopharmaceuticals shares in Q4 2016, an estimated $636K.
Alder Biopharmaceuticals made up 0.01% of BlackRock Advisors's portfolio in Q4 2016, its #1112 holding.
BlackRock Advisors first reported a position in Alder Biopharmaceuticals in Q2 2014 and has held it in 11 quarters since.
BlackRock Advisors's Alder Biopharmaceuticals position peaked at $36.3M in Q2 2015.
145 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.